Sales Support:
sales@worldwidemarketreports.com
U.S. :+1 415 871 0703
U.K. :+44-203-289-4040
AUS. : +61-2-4786-0457
INDIA :+91-848-285-0837
Menu Icon Close Icon
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

Global Pain Management Drugs Market Demand and Pipeline Insights (2022 Edition) - Analysis By Drug Type, Route of Administration, End-Use, Availability, Sales Channel, By Region, By Country: Market Insights & Forecast with Impact of COVID-19 (2023-2028)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Executive Summary

According to Azoth Analytics research report published in September 2022, the global Pain Management Drugs market was valued at USD 82.12 million in the year 2021 with Americas leading the regional market share.

The global Pain Management Drugs Market is driven by an increasing number of Chronic Pain diseases and the prevalence of cancer pain worldwide. Additionally, a growing population in which the number of geriatric population is high in several developing countries is anticipated to propel the growth of the global Pain Management drugs market.

Additionally, life expectancy has increased due to various healthcare reforms in major economies such as the U.S., Japan, and China. This is likely to drive demand for many Pain Management drugs for advanced stages of cancer, chronic pain conditions and post-operative pain management drugs.

The COVID- 19 pandemic had a mixed impact on the Global Pain Management Drugs market by affecting the drug supply chain dramatically which led to hindrances in the production and sale of opiates which are the most prominent Pain management drug in the market in key producing countries such as Afghanistan and Myanmar. Paracetamol was recommended for use by various healthcare authorities across the world, to manage fever and mild pain in adults and children with COVID-19, which boosted the demand for the drug. Moreover, India and China being the chief API suppliers for Paracetamol drugs were unable to supply the APIs due to restrictions imposed due to COVID -19 which led to manufacturing restraints and shortages in many European countries.



Scope of the Report

• The report presents insights on the 28 major drug development pipelines for Pain Management.

• The report presents the analysis of the Pain Management Drugs Market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.

• The report analyses the Pain Management Drugs Market by Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics, Others).

• The report analyses the Pain Management Drugs Market by Route of Administration (Topical, Intravenous, Oral, Others).

• The report analyses the Pain Management Drugs Market by End-use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain).

• The report analyses the Pain Management Drugs Market by Availability (Over the Counter (OTC), Prescription).

• The report analyses the Pain Management Drugs Market by Sales Channel (Retail Pharmacies, Hospital Pharmacies and E-commerce).

• The Global Pain Management Drugs Market has been analysed By Region (Americas, Europe, Asia Pacific, and MEA).

• The Global Pain Management Drugs Market has been analysed By Country (United States, Canada, Germany, U.K, France, Spain, Italy, China, Japan and India).

• The key insights of the report have been presented through the leading company shares. Also, the attractiveness of the market has been presented by region, by Drug Class, by Indication, by End User, by Formulation, and by Distribution Channel.

• Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.

• The report tracks competitive developments, strategies, and recent developments. The companies analysed in the report include Pfizer, Johnson and Johnson, GSK Plc., Bristol-Myers Squibb, AbbVie, Bayer, Boehringer Ingelheim, Novartis, Teva Pharmaceutical, Sanofi, Amgen.

Key Target Audience

• Pain Management Drugs Companies

• Healthcare and Pharmaceutical Companies

• Research and Development (R&D) Organizations

• Government Bodies & Regulating Authorities

• Investment Banks and Equity Firms

1. Report Scope and Methodology

1.1 Scope of the Report

1.2 Research Methodology

1.3 Executive Summary

2. Strategic Recommendations

3. Global Pain Management Drugs Market: Product Overview

4. Global Pain Management Drugs Market: Pipeline Analysis

4.1. Competitive Positioning of Prominent companies with Pain management Drugs in their Pipeline

4.2 Investigational New Drug

4.2.1 Basimglurant (NOE-101), Drug Description and Outcomes

4.3 Phase I

4.3.1 Resiniferatoxin (RTX), Drug Description and Outcomes

4.3.2 VX-548, Drug Description and Outcomes

4.4 Phase - II/III

4.4.1 TLC590, Bupivacaine, Drug Description and Outcomes

4.5 Phase II

4.5.1 BAY2395840, Drug Description and Outcomes

4.5.2 Libvatrep- SAF312, Drug Description and Outcomes

4.5.3 Trametinib, Drug Description and Outcomes

4.5.4 Canakinumab + LNA043, Drug Description and Outcomes

4.5.5 Erenumab-aooe (EREN), Drug Description and Outcomes

4.5.6 Erenumab-Aooe (AimovigÆ), Drug Description and Outcomes

4.5.7 Erenumab-Aooe 70 MG, Drug Description and Outcomes

4.5.8 BOTOX (onabotulinumtoxinA) , Drug Description and Outcomes

4.5.9 Resiniferatoxin, Drug Description and Outcomes

4.5.10 Resiniferatoxin, Zilretta, Drug Description and Outcomes

4.5.11 LY3526318, Drug Description and Outcomes

4.5.12 LY3526318, Drug Description and Outcomes

4.5.13 Quinagolide (FE 999051), Drug Description and Outcomes

4.5.14 HMI-115, Drug Description and Outcomes

4.6 Phase III

4.6.1 Secukinumab, Drug Description and Outcomes

4.6.2 Venglustat (GZ402671) , Drug Description and Outcomes

4.6.3 Elagolix + Estradiol/Norethindrone Acetate, Drug Description and Outcomes

4.6.4 Elagolix + Combined Oral Contraceptive (COC), Drug Description and Outcomes

4.6.5 Ibuprofen PR (300 mg and 200 mg), Drug Description and Outcomes

4.6.6 Ibuprofen Liquid Capsules (200 mg), Drug Description and Outcomes

4.6.7 Intravenous (IV) tramadol (AVE-901), Drug Description and Outcomes

4.7 Phase IV

4.7.1 Catapresan, Drug Description and Outcomes

4.7.2 Ubrogepant 50 MG, 100MG, Drug Description and Outcomes Galcanezumab, Drug Description and Outcomes Erenumab Prefilled Syringe, Drug Description and Outcomes

5. Global Pain Management Drugs Market: An Analysis

5.1. Assessment of Macro-Economic Indicators of Global Pain Management Drugs Market

5.2. Pain Management Drugs Market

5.3 Market Size, By Value, 2018-2028

5.4 Global Pain Management Drugs Market: Growth and Forecast

5.5 Impact of COVID-19 on Global Pain Management Drugs Market

6. Global Pain Management Drugs Market: Segment Analysis By Drug Type

6.1 Global Pain Management Drugs Market Segmentation, By Drug Type

6.2 Competitive Positioning of Pain Management Drugs Market: By Drug Type (2021 & 2028)

6.3 By Acetaminophen, By Value (USD Million), 2018-2028

6.4 By NSAIDs, By Value (USD Million), 2018-2028

6.5 By Narcotics (opioids), By Value (USD Million), 2018-2028

6.6 By Others, By Value (USD Million), 2018-2028

7. Global Pain Management Drugs Market: Segment Analysis By Route of Administration

7.1 Global Pain Management Drugs Market Segmentation, By Route of Administration

7.2 Competitive Positioning of Pain Management Drugs Market: By Route of Administration (2021 & 2028)

7.3 By Topical, By Value (USD Million), 2018-2028

7.4 By Intravenous, By Value (USD Million), 2018-2028

7.5 By Oral, By Value (USD Million), 2018-2028

7.6 By Others, By Value (USD Million), 2018-2028

8. Global Pain Management Drugs Market: Segment Analysis By End Use

8.1 Global Pain Management Drugs Market Segmentation, By End Use

8.2 Competitive Positioning of Pain Management Drugs Market: By End Use (2021 & 2028)

8.3 By Inflammation, By Value (USD Million), 2018-2028

8.4 By Neuropathic Pain, By Value (USD Million), 2018-2028

8.5 By Musculoskeletal Pain, By Value (USD Million), 2018-2028

8.6 By Severe and Chronic Pain, By Value (USD Million), 2018-2028

9. Global Pain Management Drugs Market: Segment Analysis By Availability

9.1 Global Pain Management Drugs Market Segmentation, By Availability

9.2 Competitive Positioning of Pain Management Drugs Market: By Availability (2021 & 2028)

9.3 By Prescription, By Value (USD Million), 2018-2028

9.4 By Over The Counter (OTC), By Value (USD Million), 2018-2028

10. Global Pain Management Drugs Market: Segment Analysis

10.1 Global Pain Management Drugs Market Segmentation, By Sales Channel

10.2 Competitive Positioning of Pain Management Drugs Market: By Sales Channel (2021 & 2028)

10.3 By Hospital Pharmacies, By Value (USD Million), 2018-2028

10.4 By Retail Pharmacies, By Value (USD Million), 2018-2028

10.5 By E-commerce, By Value (USD Million), 2018-2028

11. Global Pain Management Drugs Market: Regional Analysis

11.1 Competitive Positioning of Global Pain Management Drugs Market: By Region (2021 & 2028)

12. Americas Pain Management Drugs Market: An Analysis (2018-2028)

12.1 Assessment of Macro-Economic Indicators of Americas Pain Management Drugs Market

12.2 Americas Pain Management Drugs Market- Size and Forecast, By Value (2018-2028)

12.3 Americas Pain Management Drugs Market

12.4 Americas Pain Management Drugs Market: Prominent Companies

12.5 Americas Pain Management Drugs Market: Segment Analysis

12.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value

12.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value

12.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value

12.9 Market Segmentation By Availability (OTC, Prescription), By Value

12.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value

12.13 Americas Pain Management Drugs Market: Country Analysis

12.14 Market Opportunity Chart of Americas Pain Management Drugs Market - By Country, By Value (Year-2028)

12.15 Competitive Positioning of Americas Pain Management Drugs Market - By Country

12.16 United States Pain Management Drugs Market: Size and Forecast (2018-2028)

12.17 United States Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration, By End use, By Availability By Sales Channel (2018-2028)

12.18 Canada Pain Management Drugs Market: Size and Forecast (2018-2028)

12.19 Canada Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

13. Europe Pain Management Drugs Market: An Analysis (2018-2028)

13.1 Assessment of Macro-Economic Indicators of Europe Pain Management Drugs Market

13.2 Europe Pain Management Drugs Market By value: Size and Forecast (2018-2028)

13.3 Europe Pain Management Drugs Market

13.4 Europe Pain Management Drugs Market: Prominent Companies

13.5 Europe Pain Management Drugs Market: Segment Analysis

13.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value

13.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value

13.4 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value

13.5 Market Segmentation By Availability (OTC, Prescription), By Value

13.6 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value

13.7 Europe Pain Management Drugs Market: Country Analysis

13.8 Market Opportunity Chart of Europe Pain Management Drugs Market - By Country, By Value (Year-2028)

13.9 Competitive Positioning of Europe Pain Management Drugs Market - By Country

13.10 Germany Pain Management Drugs Market: Size and Forecast (2018-2028)

13.11 Germany Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)

13.12 United Kingdom Pain Management Drugs Market: Size and Forecast (2018-2028)

13.13 United Kingdom Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)

13.14 France Pain Management Drugs Market: Size and Forecast (2018-2028)

13.15 France Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)

13.16 Spain Pain Management Drugs Market: Size and Forecast (2018-2028)

13.17 Spain Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)

13.18 Italy Pain Management Drugs Market: Size and Forecast (2018-2028)

13.19 Italy Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)

14 APAC Pain Management Drugs Market: An Analysis (2018-2028)

14.1 Assessment of Macro-Economic Indicators of APAC Pain Management Drugs Market

14.2 APAC Pain Management Drugs Market By value: Size and Forecast (2018-2028)

14.3 APAC Pain Management Drugs Market

14.4 APAC Pain Management Drugs Market: Prominent Companies

14.5 APAC Pain Management Drugs Market: Segment Analysis

14.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs) , Narcotics (opioids), Others) By Value

14.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value

14.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value

14.9 Market Segmentation By Availability (OTC, Prescription), By Value

14.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value

14.11 APAC Pain Management Drugs Market: Country Analysis

14.12 Market Opportunity Chart of APAC Pain Management Drugs Market - By Country, By Value (Year-2028)

14.13 Competitive Positioning of APAC Pain Management Drugs Market - By Country

14.14 China Pain Management Drugs Market: Size and Forecast (2018-2028)

14.15 China Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

14.16 Japan Pain Management Drugs Market: Size and Forecast (2018-2028)

14.7 Japan Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

14.8 India Pain Management Drugs Market: Size and Forecast (2018-2028)

14.9 India Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

15. Middle East and Africa Pain Management Drugs Market

15.1 Assessment of Macro-Economic Indicators of MEA Pain Management Drugs Market

15.2 Middle East and Africa Pain Management Drugs Market By value: Size and Forecast (2018-2028)

15.3 Market Segmentation By Drug Type (Antibiotics, Antifungals, Astringents, Antipruritic, Analgesics, Others)

15.4 Market Segmentation By Route of Administration (Skin Disease, Pain Management, Eye and Ear Care, Others), By Value

15.5 Market Segmentation By End use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Others), By Value

15.6 Market Segmentation By Availability (Prescription, Over The Counter (OTC), Others), By Value

15.7 Market Segmentation By Sales Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Value

16. Global Pain Management Drugs Market Dynamics

16.1 Global Pain Management Drugs Market Drivers

16.2 Global Pain Management Drugs Market Restraints

16.3 Global Pain Management Drugs Market Trends

17. Market Attractiveness and Strategic Analysis

17.1 Market Attractiveness Chart of Global Pain Management Drugs Market - By Drug Type (2028)

17.2 Market Attractiveness Chart of Global Pain Management Drugs Market - By Route of Administration (2028)

17.3 Market Attractiveness Chart of Global Pain Management Drugs Market - By End-use (2028)

17.4 Market Attractiveness Chart of Global Pain Management Drugs Market - By Availability (2028)

17.5 Market Attractiveness Chart of Global Pain Management Drugs Market - By Sales Channel (2028)

17,6 Market Attractiveness Chart of Global Pain Management Drugs Market - By Region (2028)

18. Competitive Landscape

18.1 Market Share of global leading companies

19. Company Profiles (Business Description, Financial Analysis, Business Strategy)

19.1 Pfizer Inc.

19.2 Johnson & Johnson

19.3 GSK plc.

19.4 Bristol-Myers Squibb Company

19.5 Bayer AG

19.6 Boehringer Ingelheim

19.7 AbbVie Inc.

19.8 Teva pharmaceuticals

19.9 Sanofi

19.10 Amgen

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.

Related Reports

Reagent Inventory Management Systems Market Size And Share Analysis - Growth Trends And Forec...
View More
Reputation Management Services Market Size And Share Analysis - Growth Trends And Forecasts (...
View More
Pre-Contract Management Market Size And Share Analysis - Growth Trends And Forecasts (2024-20...
View More
Intelligent Equipment Management System Market Size And Share Analysis - Growth Trends And Fo...
View More
Pool Vehicle Management Systems Market Size And Share Analysis - Growth Trends And Forecasts...
View More

Trusted Clients
A-T- Kearney.png
AbbVie.png
Agrinos.png
AIF-Metrics.png
Akzo-Nobel.jpg
Alfi-GMBH.png
Allergan.png
Almasra-Scientific-Bureau.jpg
ALPMA.jpg
Americana-Foods.png
ANP.png
Aptar-Group-Germany.jpg
asahi-kasei.png
ATC.png
atlas-servair.jpg
ATOS.png
Avalon.png
biofishency.png
biomx.png
borealisgroup.png
Cape-Peninsula.png
CBRE.png
Cennerv-Pharma.jpg
Clearponds.png
Compass-Group.png
Cortag-Industria.png
Covis-Pharma.jpg
DAIMLER-AG.jpg
Edipresse-Media.jpg
Epson.png
Evonik-Industries-AG.png
ExcelSource.png
Fingo.png
Firstkind.png
FLM-Foodingredients.png
Freudenberg.png
Fueltrax.jpg
Fugro-International.png
Fuji-Films.png
Funky-Sound-Studio.png
GALTWAY.png
Gartner.png
GBSC.png
Global-Information.jpg
Hanwha-Total-Petrochemical.png
Hebrew.png
Horiba-Mira.png
Hunter-and-Co-Investments.png
Hyosung.png
Hyssopus-Organics.jpg
IBSA.png
Ideagen.png
IMS.png
InSinkErator.png
Intas-Pharma.png
IntelMed-Sarl.png
Interdiligence-Consulting.png
Israel-Shopyards.png
Johnsons-Controls.png
kakaxi.jpg
KORDSA.png
kotra.png
KPMG.png
lantmannen.png
LEK.png
LG.jpg
Makuri-Technology.jpg
Mallinckrodt.png
Mappo.png
Maprimed.jpg
mcns.jpg
MED-EL.png
Mehr-Azin-Pouya-Sahand.png
Molkerei-Ammerland-eG.png
Monty-Holding.jpg
mpmaterials.png
Mundipharma.png
Nasco.png
Nitto.png
Nouryon.png
NOXTAK.png
Oskars.png
Paidotribo.png
Parnell-Pharmaceuticals.png
Podravka.png
ppg.png
Privi.png
Publicis Groupe.png
Qvetech.jpg
R3P.jpg
Samsung.png
Sapient.png
SEW-EURODRIVE.png
Shivananda.jpg
Silver-Clouds.png
SMIT.jpg
SOLVIAS.png
Spectrum.png
SR-Instruments-Oy.png
Star-Seed.png
Stryker -ENT.png
Synjenta.png
Terumo-Corp.png
TherOzone.png
Toshiba.png
TT-Electronics.png
umbc.edu.png
Vard.jpg
Vital-Xense.png
Walraven.png
Wlgore.png
Woodmac.png
WWF-UK.png
ZENOAQ.png
Zuellig-Pharma.png
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

phoneiconU.S. : +1 415 871 0703

phoneiconU.K. : +44-203-289-4040

phoneiconAUS. :+61-2-4786-0457

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved